Teladoc Q2 FY26 net loss widens 19% to USD 38.9 million; revenue drops 4% to USD 606.9 million - TDOC News | RalliesTeladoc Q2 FY26 net loss widens 19% to USD 38.9 million; revenue drops 4% to USD 606.9 million
T
TDOC• Second-quarter results
- Teladoc Health posted Q2 2026 revenue of USD 606.9 million, down 4% from a year earlier.
- Net loss widened to USD 38.9 million, or USD 0.21 per share.
- Non-GAAP adjusted EBITDA slipped 5% to USD 65.7 million, as BetterHelp’s adjusted EBITDA fell to USD 471,000 from USD 11.86 million.
- Integrated Care revenue rose 1% to USD 394.3 million, while BetterHelp revenue dropped 12% to USD 212.6 million on accelerating cash-pay pressure.
Outlook and product update
- Teladoc launched Teladoc One in the U.S. and cut its full-year revenue outlook to USD 2.36 billion–USD 2.45 billion.
- The company sees non-GAAP adjusted EBITDA of USD 271 million–USD 303 million.
WFG
•
